Table 1. Baseline characteristics of the study participants .
| Variables | With NAFLD (58 patients) | Without NAFLD (142 patients) | P value |
| Age (year) | 40.71 ± 6.84 | 37.07 ± 7.03 | 0.0001 |
| Weight (kg) | 83.46 ± 9.73 | 77.44 ± 7.57 | 0.0001 |
| Height (cm) | 172.53 ± 6.27 | 174.76 ± 5.67 | 0.015 |
| BMI (kg/m2) | 28.06 ± 3.23 | 25.35 ± 2.21 | 0.0001 |
| Waist circumference (cm) | 87.75 ± 7.42 | 83.67 ± 7.24 | 0.0001 |
| Hip circumference (cm) | 101.06 ± 4.70 | 96.03 ± 4.56 | 0.0001 |
| Triglyceride (mg/dL) | 183.37 ± 73.57 | 161.62 ± 42.29 | 0.15 |
| HDL (mg/dL) | 41.50 ± 5.54 | 42.05 ± 5.28 | 0.50 |
| LDL (mg/dL) | 133.98 ± 15.99 | 129.30 ± 18.86 | 0.09 |
| Cholesterol (mg/dL) | 199.10 ± 44.09 | 184.07 ± 38.76 | 0.018 |
| FPG (mg/dL) | 88.60 ± 16.15 | 86.95 ± 10.89 | 0.40 |
| ALT (IU/L) | 38.56 ± 17.61 | 20.76 ± 6.40 | 0.0001 |
| AST (IU/L) | 23.98 ± 8.97 | 22.92 ± 6.37 | 0.34 |
| ALP (IU/L) | 159.96 ± 43.46 | 160.90 ± 33.70 | 0.87 |
| Albumin (mg/dL) | 4.33 ± 0.43 | 4.38 ± 0.36 | 0.37 |
NAFLD: Non-alcoholic fatty liver disease; BMI: body mass index; LDL: Low density lipoprotein; HDL: high density lipoprotein; FPG: fasting plasma glucose; ALT: alanine aminotransferase; ALP: Alkaline phosphatase; AST: Aspartate aminotransferase; kg: kilogram; cm: centimeter